1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Tumor Transcriptomics Market
5.
Voice of Customer
5.1.
Service Awareness
5.2.
Cancer Prevalence, By Gender
5.3.
Cancer Prevalence, By Age Group
5.4.
Cancer Prevalence, By Type
5.5.
Cancer Prevalence, By Region
5.6.
Benefits of Using Tumor Transcriptomics
5.7.
Commonly Used Technology in Tumor Transcriptomics
6. Clinical Trial
Analysis
7. Global Tumor
Transcriptomics Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Tumor Type (Breast Cancer, Lung Cancer, Colorectal
Cancer, Prostate Cancer, Melanoma, Others)
7.2.2.
By Technology (Microarray, Real-Time Quantitative,
Polymerase Chain Reaction (Q-PCR), Others)
7.2.3.
By Product (Consumables, Instrument, Software &
Services)
7.2.4.
By Application (Diagnostics and Disease Profiling, Drug
Discovery, Others)
7.2.5.
By End User (Biotechnology & Pharmaceutical
Companies, Research & Academic Institutions, Others)
7.2.6.
By Company (2021)
7.2.7. By
Region
7.3.
Product Market Map
8. North America Tumor
Transcriptomics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Tumor Type
8.2.2.
By Technology
8.2.3.
By Product
8.2.4.
By Application
8.2.5.
By End User
8.2.6.
By Country
8.3.
North America: Country Analysis
8.3.1.
United States Tumor Transcriptomics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Tumor Type
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Product
8.3.1.2.4.
By Application
8.3.1.2.5.
By End User
8.3.2.
Mexico Tumor Transcriptomics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Tumor Type
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Product
8.3.2.2.4.
By Application
8.3.2.2.5.
By End User
8.3.3.
Canada Tumor Transcriptomics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Tumor Type
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Product
8.3.3.2.4.
By Application
8.3.3.2.5.
By End User
9. Europe Tumor
Transcriptomics Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Tumor Type
9.2.2.
By Technology
9.2.3.
By Product
9.2.4.
By Application
9.2.5.
By End User
9.2.6.
By Country
9.3.
Europe: Country Analysis
9.3.1.
France Tumor Transcriptomics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Tumor Type
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Product
9.3.1.2.4.
By Application
9.3.1.2.5.
By End User
9.3.2.
Germany Tumor Transcriptomics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Tumor Type
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Product
9.3.2.2.4.
By Application
9.3.2.2.5.
By End User
9.3.3.
United Kingdom Tumor Transcriptomics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Tumor Type
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Product
9.3.3.2.4.
By Application
9.3.3.2.5.
By End User
9.3.4.
Italy Tumor Transcriptomics Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Tumor Type
9.3.4.2.2.
By Technology
9.3.4.2.3.
By Product
9.3.4.2.4.
By Application
9.3.4.2.5.
By End User
9.3.5.
Spain Tumor Transcriptomics Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Tumor Type
9.3.5.2.2.
By Technology
9.3.5.2.3.
By Product
9.3.5.2.4.
By Application
9.3.5.2.5.
By End User
10. Asia-Pacific Tumor
Transcriptomics Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Tumor Type
10.2.2.
By Technology
10.2.3.
By Product
10.2.4.
By Application
10.2.5.
By End User
10.2.6.
By Country
10.3.
Asia-Pacific: Country Analysis
10.3.1.
China Tumor Transcriptomics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Tumor Type
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Product
10.3.1.2.4.
By Application
10.3.1.2.5.
By End User
10.3.2.
India Tumor Transcriptomics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Tumor Type
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Product
10.3.2.2.4.
By Application
10.3.2.2.5.
By End User
10.3.3.
South Korea Tumor Transcriptomics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Tumor Type
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Product
10.3.3.2.4.
By Application
10.3.3.2.5.
By End User
10.3.4.
Japan Tumor Transcriptomics Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Tumor Type
10.3.4.2.2.
By Technology
10.3.4.2.3.
By Product
10.3.4.2.4.
By Application
10.3.4.2.5.
By End User
10.3.5.
Australia Tumor Transcriptomics Market Outlook
10.3.5.1.
Market Size & Forecast
10.3.5.1.1.
By Value
10.3.5.2.
Market Share & Forecast
10.3.5.2.1.
By Tumor Type
10.3.5.2.2.
By Technology
10.3.5.2.3.
By Product
10.3.5.2.4.
By Application
10.3.5.2.5.
By End User
11. South America Tumor Transcriptomics
Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Tumor Type
11.2.2.
By Technology
11.2.3.
By Product
11.2.4.
By Application
11.2.5.
By End User
11.2.6.
By Country
11.3.
South America: Country Analysis
11.3.1.
Brazil Tumor Transcriptomics Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Tumor Type
11.3.1.2.2.
By Technology
11.3.1.2.3.
By Product
11.3.1.2.4.
By Application
11.3.1.2.5.
By End User
11.3.2.
Argentina Tumor Transcriptomics Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Tumor Type
11.3.2.2.2.
By Technology
11.3.2.2.3.
By Product
11.3.2.2.4.
By Application
11.3.2.2.5.
By End User
11.3.3.
Colombia Tumor Transcriptomics Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Tumor Type
11.3.3.2.2.
By Technology
11.3.3.2.3.
By Product
11.3.3.2.4.
By Application
11.3.3.2.5.
By End User
12. Middle East and
Africa Tumor Transcriptomics Market Outlook
12.1.
Market Size & Forecast
12.1.1.
By Value
12.2.
Market Share & Forecast
12.2.1.
By Tumor Type
12.2.2.
By Technology
12.2.3.
By Product
12.2.4.
By Application
12.2.5.
By End User
12.2.6.
By Country
12.3.
MEA: Country Analysis
12.3.1.
South Africa Tumor Transcriptomics Market Outlook
12.3.1.1.
Market Size & Forecast
12.3.1.1.1.
By Value
12.3.1.2.
Market Share & Forecast
12.3.1.2.1.
By Tumor Type
12.3.1.2.2.
By Technology
12.3.1.2.3.
By Product
12.3.1.2.4.
By Application
12.3.1.2.5.
By End User
12.3.2.
Saudi Arabia Tumor Transcriptomics Market Outlook
12.3.2.1.
Market Size & Forecast
12.3.2.1.1.
By Value
12.3.2.2.
Market Share & Forecast
12.3.2.2.1.
By Tumor Type
12.3.2.2.2.
By Technology
12.3.2.2.3.
By Product
12.3.2.2.4.
By Application
12.3.2.2.5.
By End User
12.3.3.
UAE Tumor Transcriptomics Market Outlook
12.3.3.1.
Market Size & Forecast
12.3.3.1.1.
By Value
12.3.3.2.
Market Share & Forecast
12.3.3.2.1.
By Tumor Type
12.3.3.2.2.
By Technology
12.3.3.2.3.
By Product
12.3.3.2.4.
By Application
12.3.3.2.5.
By End User
13.
Market Dynamics
13.1.
Drivers
13.2.
Challenges
14.
Market Trends & Developments
15.
Competitive Landscape (Inclusive of SWOT Analysis of
Players Profiled)
15.1.
Thermo Fischer Scientific, Inc.
15.2.
Caris Life Sciences, Inc.
15.3.
Illumina, Inc.
15.4.
NanoString Technologies, Inc.
15.5.
10x Genomics, Inc.
15.6.
Agilent Technologies, Inc.
15.7.
Bio-Rad Laboratories, Inc.
15.8.
F. Hoffmann-La Roche AG
15.9.
Fluidigm Corporation
15.10.
Pacific Biosciences of California, Inc.
16. Strategic Recommendations